Member Board of Directors, Executive Director Strategy and Business Development
Omnitura Therapeutics is a clinical stage company that is commercializing Aneustat™, the world's first multivalent immuno-oncology drug candidate. Aneustat™ has successfully completed a phase I/IIa clinical trial in cancer patients and is now entering phase II clinical trials for prostate cancer. For more information, please visit www.omnitura.com.